https://www.marketscreener.com/quote/stock/CELLECTIS-S-A-42457/news/Cellectis-S-A-Reports-Encouraging-Clinical-Data-from-BALLI-01-Study-in-Relapsed-Refractory-B-cell-37304588/?utm_source=telegram&utm_medium=social&utm_campaign=share